The 4th Liquid Biopsy for Precision Oncology East Coast Summit returned to Boston with a refreshed agenda, sharpened focus, and a renewed mission: to accelerate access to more sensitive, less invasive testing by addressing the most pressing challenges across the entire patient care continuum.

This forum brought together leaders in Biomarker Development, Translational Research, Diagnostics, Clinical Development, Pathology, and beyond, as the go-to East Coast forum for diving deep into the barriers slowing the adoption of liquid biopsy technologies.

Attendees took home actionable insights to ensure they are maximizing the value of liquid biopsies in therapeutic development strategies.